We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · September 28, 2022

Five-Gene Signature–Based Model for the Prediction of Progression-Free Survival in Patients With Prostate Cancer

Frontiers in Oncology


Additional Info

Frontiers in Oncology
Gene expression analysis reveals a 5-gene signature for progression-free survival in prostate cancer
Front Oncol 2022 Sep 01;12(2022)914078, Z Mou, J Spencer, B Knight, J John, P McCullagh, JS McGrath, LW Harries

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading